Today’s Star Tribune features a story on a promising measles vaccine trial for blood cancer. We’re sharing this because MOCA has been investing in the development of a measles vaccine for ovarian cancer. With your support, this is just the sort of research development that MOCA makes possible. We hope you join us tomorrow night at our Annual Meeting, where we’ll award a record $530,000 to Minnesota ovarian cancer researchers. RSVP at mnovarian.org.
Posted on: Wed, 14 May 2014 15:42:27 +0000
Trending Topics
Recently Viewed Topics
© 2015